NCT02716662View on ClinicalTrials.gov

Safety of Caprylic Triglycerides in ALS: A Pilot Study

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

May 1, 2017

Study Completion Date

April 25, 2018

Conditions
ALS
Interventions
DIETARY_SUPPLEMENT

Axona

medical powder, supplement food

Trial Locations (1)

10021

Weill Cornell Medical Center, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT02716662 - Safety of Caprylic Triglycerides in ALS: A Pilot Study | Biotech Hunter | Biotech Hunter